scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00018-013-1505-Z |
P698 | PubMed publication ID | 24196749 |
P50 | author | Kristina Schoonjans | Q28468900 |
P2093 | author name string | Maaike H Oosterveer | |
P2860 | cites work | O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins | Q70345116 |
The hyperlipidemia in glycogen storage disease | Q70893481 | ||
Hyperlipemia in children with liver glycogen disease | Q70973806 | ||
Two CACGTG Motifs with Proper Spacing Dictate the Carbohydrate Regulation of Hepatic Gene Transcription | Q72036860 | ||
Stereospecific transport of glucose in the perfused rat liver | Q72128168 | ||
Measurements of electron spin resonance with the pyruvate dehydrogenase complex from Escherichia coli. Studies on the allosteric binding site of acetyl-coenzyme A | Q72393054 | ||
Disposition of a mixed meal by the conscious dog | Q72411008 | ||
Activation of phosphofructokinase from rat tissues by 6-phosphogluconate and fructose 2,6-bisphosphate | Q72821492 | ||
Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice | Q73033704 | ||
Ribose 1,5-bisphosphate is a putative regulator of fructose 6-phosphate/fructose 1,6-bisphosphate cycle in liver | Q73669384 | ||
Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: inter-relationships with hyperglycaemia and oxidative stress | Q80489672 | ||
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas | Q82615010 | ||
Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors | Q22010918 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain | Q24290716 | ||
Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue | Q24293122 | ||
Prospero-related homeobox (Prox1) is a corepressor of human liver receptor homolog-1 and suppresses the transcription of the cholesterol 7-alpha-hydroxylase gene | Q24297189 | ||
Phosphofructokinase 1 glycosylation regulates cell growth and metabolism | Q24297510 | ||
SIRT1 deacetylates and positively regulates the nuclear receptor LXR | Q24297669 | ||
SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism | Q24298588 | ||
Multiprotein bridging factor-1 (MBF-1) is a cofactor for nuclear receptors that regulate lipid metabolism | Q24298601 | ||
Regulation of cellular metabolism by protein lysine acetylation | Q24300091 | ||
Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats | Q24310656 | ||
Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins | Q24312912 | ||
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance | Q24315875 | ||
Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib | Q24320082 | ||
Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity | Q24336875 | ||
The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation | Q24336894 | ||
Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer | Q24337240 | ||
Hexosamines, insulin resistance, and the complications of diabetes: current status | Q24538581 | ||
MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network | Q24551066 | ||
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity | Q24595845 | ||
Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression | Q24632160 | ||
Lysine acetylation: codified crosstalk with other posttranslational modifications | Q24644959 | ||
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange | Q24648525 | ||
Molecular physiology of mammalian glucokinase | Q24653018 | ||
Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK | Q26825322 | ||
Sirtuins as regulators of metabolism and healthspan | Q26828939 | ||
Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders | Q27001404 | ||
Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in Drosophila | Q27323381 | ||
Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry | Q27334695 | ||
The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 | Q27652923 | ||
Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription | Q27937972 | ||
Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity | Q28141169 | ||
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 | Q28237795 | ||
CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability | Q28245419 | ||
The Sir2 family of protein deacetylases | Q28266179 | ||
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review) | Q28394917 | ||
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase | Q28508079 | ||
The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX | Q28511983 | ||
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism | Q28513195 | ||
The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR | Q28513664 | ||
O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination | Q28513755 | ||
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats | Q28581400 | ||
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver | Q28583240 | ||
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation | Q28592904 | ||
Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A | Q28594080 | ||
Critical nodes in signalling pathways: insights into insulin action | Q29614735 | ||
ATP-citrate lyase links cellular metabolism to histone acetylation | Q29615367 | ||
New nomenclature for chromatin-modifying enzymes | Q29616425 | ||
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis | Q29617241 | ||
A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose | Q30437005 | ||
Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis | Q47927518 | ||
Pyruvate carboxylase | Q48464317 | ||
ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver | Q50336015 | ||
Coenzyme A and its thioester pools in fasted and fed rat tissues. | Q51389505 | ||
Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway. | Q51551557 | ||
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. | Q51665999 | ||
The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. | Q54426511 | ||
Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. | Q54538841 | ||
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans | Q60462242 | ||
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver | Q61203329 | ||
Glucose 6-Phosphate Produced by Glucokinase, but Not Hexokinase I, Promotes the Activation of Hepatic Glycogen Synthase | Q63224144 | ||
Differential Metabolic Effects of Adenovirus-mediated Glucokinase and Hexokinase I Overexpression in Rat Primary Hepatocytes | Q63224151 | ||
GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha | Q64377758 | ||
The disposal of an oral glucose load in healthy subjects. A quantitative study | Q69896265 | ||
Nuclear receptors and the control of metabolism | Q35041181 | ||
The metabolically benign and malignant fatty liver | Q35123495 | ||
A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome | Q35140884 | ||
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. | Q35149156 | ||
Evolution of the Max and Mlx networks in animals | Q35224604 | ||
Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation | Q35345655 | ||
The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetylation coordinates organ-specific fuel switching | Q35485292 | ||
Hepatocytes: critical for glucose homeostasis | Q35733130 | ||
O-GlcNAc signalling: implications for cancer cell biology | Q35793071 | ||
O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver | Q35796929 | ||
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease | Q35804446 | ||
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease | Q35809618 | ||
Cellular metabolism and disease: what do metabolic outliers teach us? | Q35915928 | ||
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans | Q36005304 | ||
LRH-1-dependent glucose sensing determines intermediary metabolism in liver | Q36129076 | ||
Mechanistic insights into the regulation of metabolic enzymes by acetylation | Q36135254 | ||
Mio/dChREBP coordinately increases fat mass by regulating lipid synthesis and feeding behavior in Drosophila. | Q36243408 | ||
Glucose as a regulator of eukaryotic gene transcription | Q36306015 | ||
Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. | Q36315965 | ||
Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes | Q36523378 | ||
Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia | Q36635387 | ||
Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression | Q36657518 | ||
Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. | Q36693487 | ||
Hepatic glucose sensing is required to preserve β cell glucose competence | Q36733443 | ||
Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites. | Q36792618 | ||
Regulation of Akt signaling by O-GlcNAc in euglycemia. | Q36956006 | ||
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health | Q37088326 | ||
Influence of metabolism on epigenetics and disease | Q37177814 | ||
Cracking the O-GlcNAc code in metabolism. | Q37197417 | ||
Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver | Q37200875 | ||
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas | Q37214995 | ||
Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism | Q37266937 | ||
Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. | Q37333458 | ||
The role of the lipogenic pathway in the development of hepatic steatosis. | Q37386081 | ||
FoxO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by resveratrol | Q37431323 | ||
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states | Q37445714 | ||
Physiologic action of glucagon on liver glucose metabolism | Q37726825 | ||
Functional lysine modification by an intrinsically reactive primary glycolytic metabolite | Q37734916 | ||
Brain, liver, intestine: a triumvirate to coordinate insulin sensitivity of endogenous glucose production | Q37826508 | ||
An extended Myc network contributes to glucose homeostasis in cancer and diabetes. | Q37881596 | ||
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis | Q37928607 | ||
The many faces of insulin-like peptide signalling in the brain | Q37994953 | ||
Allosteric post-translational modification codes | Q38033852 | ||
O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation. | Q38059293 | ||
Novel insights into ChREBP regulation and function. | Q38099905 | ||
O-GlcNAc cycling: a link between metabolism and chronic disease | Q38103951 | ||
Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination | Q38119185 | ||
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. | Q38311106 | ||
O-GlcNAc regulates FoxO activation in response to glucose | Q30439420 | ||
The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine | Q33625053 | ||
Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc | Q33802435 | ||
c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes | Q33874328 | ||
The SLC2 (GLUT) family of membrane transporters | Q33926133 | ||
Diabetes mellitus, fasting glucose, and risk of cause-specific death | Q33945937 | ||
Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. | Q33953637 | ||
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function | Q33966115 | ||
Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. | Q33980061 | ||
Evolution and regulatory role of the hexokinases | Q34066227 | ||
Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner | Q34107422 | ||
The key role of anaplerosis and cataplerosis for citric acid cycle function. | Q34135762 | ||
Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR. | Q34148239 | ||
Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. | Q34195003 | ||
The impact of acetylation and deacetylation on the p53 pathway | Q34199692 | ||
Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes | Q34214063 | ||
A novel N-terminal domain may dictate the glucose response of Mondo proteins | Q34233730 | ||
A two-way street: reciprocal regulation of metabolism and signalling. | Q34259242 | ||
Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry | Q34298938 | ||
Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock | Q34326979 | ||
Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code | Q34359019 | ||
Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes | Q34387089 | ||
The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism | Q34411887 | ||
Direct Recruitment of Insulin Receptor and ERK Signaling Cascade to Insulin-Inducible Gene Loci | Q34448627 | ||
Protein posttranslational modifications: the chemistry of proteome diversifications | Q34465021 | ||
Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet | Q34471563 | ||
Genomic structure of the human glucose 6-phosphate translocase gene and novel mutations in the gene of a Japanese patient with glycogen storage disease type Ib. | Q34483795 | ||
Transcriptional regulation of metabolism | Q34511703 | ||
Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module | Q34518615 | ||
Glycogen storage disease type I: pathophysiology of liver adenomas | Q34528044 | ||
Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver | Q34532657 | ||
Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis | Q34537111 | ||
Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. | Q35027765 | ||
Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance | Q38314419 | ||
Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes | Q38345565 | ||
Constitutive hepatic glucokinase activity in db/db and ob/ob mice | Q38356475 | ||
Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism | Q39193322 | ||
Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis | Q39221068 | ||
Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter | Q39233300 | ||
Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins | Q39704929 | ||
Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). | Q39716403 | ||
Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose | Q39771613 | ||
PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding | Q39907196 | ||
Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. | Q39964105 | ||
Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes | Q40025244 | ||
A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor | Q40128752 | ||
The nuclear receptor LXR is a glucose sensor | Q40190911 | ||
Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation | Q40324625 | ||
Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells. | Q40383614 | ||
SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin | Q40415650 | ||
Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1. | Q40555996 | ||
Corepressor SMRT specifically represses the transcriptional activity of orphan nuclear receptor hB1F/hLRH-1. | Q40630685 | ||
Short-term control of glucokinase activity: role of a regulatory protein | Q40745691 | ||
Mammalian glucokinase and its gene | Q40855958 | ||
Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice | Q41447207 | ||
A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism | Q41762089 | ||
Time-dependent pseudo-activation of hepatic glycogen synthase b by glucose 6-phosphate without involvement of protein phosphatases | Q41787570 | ||
Metabolic regulation of epigenetics | Q41942880 | ||
O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability | Q42076002 | ||
ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver | Q42128898 | ||
Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen th | Q42488048 | ||
Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis | Q42681991 | ||
Activation of glucokinase gene expression by hepatic nuclear factor 4alpha in primary hepatocytes | Q43001938 | ||
Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose | Q43003369 | ||
Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs | Q43179086 | ||
Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation | Q43276273 | ||
Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048. | Q43603097 | ||
Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats | Q43778806 | ||
Adenovirus-mediated overexpression of Tcfe3 ameliorates hyperglycaemia in a mouse model of diabetes by upregulating glucokinase in the liver | Q44063015 | ||
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. | Q44123228 | ||
Pathways for glucose disposal after meal ingestion in humans | Q44244726 | ||
Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene. | Q44264131 | ||
Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene | Q44264485 | ||
The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway | Q44652125 | ||
Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression | Q44777483 | ||
Modulation of glucokinase expression by hypoxia-inducible factor 1 and upstream stimulatory factor 2 in primary rat hepatocytes | Q44889088 | ||
Lxralpha deficiency hampers the hepatic adaptive response to fasting in mice | Q44987000 | ||
Glycogen storage disease, types I to X: criteria for morphologic diagnosis | Q45174883 | ||
Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice | Q45187815 | ||
Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1 | Q45558516 | ||
Connecting threads: epigenetics and metabolism | Q46493363 | ||
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. | Q46562134 | ||
Hepatic glucose sensing via the CREB coactivator CRTC2. | Q46716195 | ||
Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. | Q47701307 | ||
P433 | issue | 8 | |
P921 | main subject | glycobiology | Q899224 |
P304 | page(s) | 1453-1467 | |
P577 | publication date | 2013-11-07 | |
P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
P1476 | title | Hepatic glucose sensing and integrative pathways in the liver | |
P478 | volume | 71 |
Q36603866 | A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism |
Q42237279 | Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity |
Q38732147 | Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control. |
Q35934280 | Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes |
Q36800168 | De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose |
Q55050296 | Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. |
Q47432485 | Effect of fibre additions to flatbread flour mixes on glucose kinetics: a randomised controlled trial |
Q92932318 | Foie gras and liver regeneration: a fat dilemma |
Q92130124 | Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice |
Q90709538 | Glucose-dependent trans-plasma membrane electron transport and p70S6k phosphorylation in skeletal muscle cells |
Q89828866 | Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia |
Q35924335 | Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals |
Q50051000 | Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? |
Q38622648 | Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism. |
Q38702671 | LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice |
Q38336909 | Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions. |
Q38905346 | Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity |
Q46304648 | Metabolic and genomic adaptations to winter fattening in a primate species, the grey mouse lemur (Microcebus murinus). |
Q46721002 | Metabolic responses of the Antarctic fishes Notothenia rossii and Notothenia coriiceps to sewage pollution |
Q38293698 | Mitochondria-associated endoplasmic reticulum membranes allow adaptation of mitochondrial metabolism to glucose availability in the liver |
Q37137283 | Molecular characterization of Tps1 and Treh genes in Drosophila and their role in body water homeostasis |
Q28066233 | Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet? |
Q96304996 | PFKFB3, a key glucose metabolic enzyme regulated by pathogen recognition receptor TLR4 in liver cells |
Q91111339 | Review: Nutrigenomics of marbling and fatty acid profile in ruminant meat |
Q64259703 | Short-Term Neonatal Oral Administration of Oleanolic Acid Protects against Fructose-Induced Oxidative Stress in the Skeletal Muscles of Suckling Rats |
Q38934814 | TRIENNIAL LACTATION SYMPOSIUM: Nutrigenomics in dairy cows: Nutrients, transcription factors, and techniques. |
Q37227732 | The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. |
Q39203339 | The role of metabolic states in development and disease. |
Q92280507 | Therapeutic Effects of Amino Acids in Liver Diseases: Current Studies and Future Perspectives |
Q49231099 | Transcription factor activity rhythms and tissue-specific chromatin interactions explain circadian gene expression across organs |
Q33838571 | Transcriptional coregulators: fine-tuning metabolism |
Q36466200 | Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity. |
Search more.